8 patents
Utility
Prodrug Compounds of 3,4-METHYLENEDIOXYMETHAMPHETAMINE (Mdma) and Methods of Synthesizing the Same
18 Jan 24
The present invention includes a novel class of MDMA carbamates that can be activated in vivo as prodrugs.
Denton W. Hoyer, Robert F. Roscow, Rong Ling, Chuanjun Gao
Filed: 26 Jul 23
Utility
Novel Fungal Compoind Formulations and Their Therapeutic Methods of Use
14 Dec 23
The present invention further relates generally to novel systems, methods, and compositions for generating pharmaceutical compositions and formulations that include one or more fungal compounds and/or extracts.
Robert F. Roscow
Filed: 28 Oct 21
Utility
Novel Psychedelic Compositions, Delivery Systems and Therapeutic Uses Thereof
16 Nov 23
The present invention provides compositions and methods for the treatment of a serotonin receptor related disease or condition in a subject in need thereof.
John C Gustin, Michael J Mccarthy
Filed: 1 Oct 21
Utility
Psilocin Prodrug Compounds and Methods of Synthesizing the Same
16 Nov 23
The present invention includes a novel class of psilocin carbamates and carbonate prodrug compounds having one or more aza substitution within the psilocin core.
Denton W. Hoyer, Robert F. Roscow
Filed: 2 May 23
Utility
Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same
2 Nov 23
The present invention is directed to novel chemical compositions of matter and their methods of synthesis, and in particular novel analogs of Psilocin having enhanced physical and pharmacokinetic characteristics.
Denton W. Hoyer, Robert F. Roscow
Filed: 1 May 23
Utility
Novel Formulations of Psilocybin And Psilocin Compounds as Serotonin Agonists in Combination With 3,4 Methylenedioxymethamphetamine (MDMA)
2 Nov 23
The present invention is directed to the use of psilocybin and/or psilocin compounds in combination with 3,4-methylenedioxymethamphetamine (MDMA) or other entactogens, to modulate activity of serotonin receptors, and preferably the 5-HT2A serotonin receptor in humans.
Robert Fletcher Roscow
Filed: 18 Sep 21
Utility
Novel Short-acting Psychoactive Compounds of the Mdma Class
12 Oct 23
The present invention is directed to novel chemical compositions of matter, and in particular novel MDMA class of compounds having substituted methylenedioxyphenethylamine and substituted amphetamine, having a metabolically labile thioether group.
Denton W. Hoyer, Robert F. Roscow, Rong Ling, Chuanjun Gao
Filed: 13 Jun 23
Utility
Novel Psilocin Analog Compositions And Methods of Synthesizing The Same
31 Aug 23
The present invention is directed to novel chemical compositions of matter and their methods of synthesis, and in particular novel analogs of Psilocin having enhanced physical and pharmacokinetic characteristics.
Denton W. Hoyer, Robert F. Roscow
Filed: 1 May 23
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first